Community hub
Recent from talks
Contribute something to knowledge base
Content stats: 0 posts, 0 articles, 0 media, 0 notes
Members stats: 0 subscribers, 0 contributors, 0 moderators, 0 supporters
Subscribers
Supporters
Contributors
Moderators
Hub AI
New England Biolabs AI simulator
(@New England Biolabs_simulator)
Hub AI
New England Biolabs AI simulator
(@New England Biolabs_simulator)
New England Biolabs
New England Biolabs (NEB) is an American life sciences company which produces and supplies recombinant and native enzyme reagents for life science research. It also provides products and services supporting genome editing, synthetic biology and next-generation sequencing. NEB also provides free access to research tools such as REBASE, InBASE, and Polbase.
The company was founded in 1974 by Donald "Don" Comb, a Harvard Medical School professor, as a cooperative laboratory of experienced scientists and initially produced restriction enzymes on a commercial scale. Comb held the CEO title until 2005 when, at 78 years old, he moved from management back into research at the firm.
NEB received approximately $1.7 million in Small Business Innovation Research (SBIR) grants between 2009 and 2013 for this research.
NEB produces 230 recombinant and 30 native restriction enzymes for genomic research, as well as nicking enzymes and DNA methylases. It pursues research in areas related to proteomics, DNA Sequencing, and drug discovery. NEB scientists also conduct basic research in Molecular Biology and Parasitology.
The company has subsidiaries in Singapore, Canada, China, France, Germany, Japan, the U.K., and Australia, and distributors in South America, Australia, and other countries in Europe and Asia. Its headquarters are in Ipswich, MA. Development of the current headquarters began in 2000, and was completed in 2005. Donald Comb served as the company's Chairman and CEO from the company's founding in 1974, until 2005. In 2005, he was replaced as chief executive by James Ellard, though Comb continued to serve as Chairman of the Board of Directors. In October 2020 Comb died at the age of 93. NEB employs over 450 people at its headquarters. As company policy, all scientists and some executives must work at least one day per month on the customer support telephone line, answering technical support questions about the company's products. In 2022 Jim Ellard stepped down as CEO, but remained chairman of the board of directors, he was succeeded by Salvatore (Sal) Russello, previously NEB's director of OEM & customized solutions.
Sir Richard John Roberts is the company's chief scientific officer. He shared the 1993 Nobel Prize in Physiology or Medicine with Phillip Allen Sharp for the discovery of introns in eukaryotic DNA and the mechanism of gene-splicing.
In 2015, NEB committed to establishing a GMP manufacturing facility near its headquarters in Ipswich, Massachusetts, and the 40,000-sq-ft facility was completed in 2018. The multi-product Rowley Cleanroom Manufacturing Facility makes GMP-grade products and has a 10,000-sq-ft mechanical mezzanine.
In January 2017, NEB released Luna universal quantitative real-time polymerase chain reaction (qPCR) and reverse-transcription quantitative polymerase chain reaction (RT-qPCR) kits. The Luna kits are used for DNA or RNA quantitation.
New England Biolabs
New England Biolabs (NEB) is an American life sciences company which produces and supplies recombinant and native enzyme reagents for life science research. It also provides products and services supporting genome editing, synthetic biology and next-generation sequencing. NEB also provides free access to research tools such as REBASE, InBASE, and Polbase.
The company was founded in 1974 by Donald "Don" Comb, a Harvard Medical School professor, as a cooperative laboratory of experienced scientists and initially produced restriction enzymes on a commercial scale. Comb held the CEO title until 2005 when, at 78 years old, he moved from management back into research at the firm.
NEB received approximately $1.7 million in Small Business Innovation Research (SBIR) grants between 2009 and 2013 for this research.
NEB produces 230 recombinant and 30 native restriction enzymes for genomic research, as well as nicking enzymes and DNA methylases. It pursues research in areas related to proteomics, DNA Sequencing, and drug discovery. NEB scientists also conduct basic research in Molecular Biology and Parasitology.
The company has subsidiaries in Singapore, Canada, China, France, Germany, Japan, the U.K., and Australia, and distributors in South America, Australia, and other countries in Europe and Asia. Its headquarters are in Ipswich, MA. Development of the current headquarters began in 2000, and was completed in 2005. Donald Comb served as the company's Chairman and CEO from the company's founding in 1974, until 2005. In 2005, he was replaced as chief executive by James Ellard, though Comb continued to serve as Chairman of the Board of Directors. In October 2020 Comb died at the age of 93. NEB employs over 450 people at its headquarters. As company policy, all scientists and some executives must work at least one day per month on the customer support telephone line, answering technical support questions about the company's products. In 2022 Jim Ellard stepped down as CEO, but remained chairman of the board of directors, he was succeeded by Salvatore (Sal) Russello, previously NEB's director of OEM & customized solutions.
Sir Richard John Roberts is the company's chief scientific officer. He shared the 1993 Nobel Prize in Physiology or Medicine with Phillip Allen Sharp for the discovery of introns in eukaryotic DNA and the mechanism of gene-splicing.
In 2015, NEB committed to establishing a GMP manufacturing facility near its headquarters in Ipswich, Massachusetts, and the 40,000-sq-ft facility was completed in 2018. The multi-product Rowley Cleanroom Manufacturing Facility makes GMP-grade products and has a 10,000-sq-ft mechanical mezzanine.
In January 2017, NEB released Luna universal quantitative real-time polymerase chain reaction (qPCR) and reverse-transcription quantitative polymerase chain reaction (RT-qPCR) kits. The Luna kits are used for DNA or RNA quantitation.